E-Co for Malignancies

Phase-Based Progress Estimates
University of Rochester, Rochester, NY
Malignancies+1 More
E-Co - Behavioral
All Sexes
What conditions do you have?

Study Summary

The objective of the study is to evaluate the feasibility of a combined mobile health exercise and cognitive rehabilitation intervention and its effect on cognition in a single-arm pilot study that recruits cancer survivors.

Eligible Conditions

  • Malignancies
  • Older Cancer Survivors (Any Cancer, Aged 60 and Over, Have Completed Curative Intent Treatments)

Treatment Effectiveness

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: Post-intervention at week 12

Week 12
Cambridge Neuropsychological Test Automated Battery (CANTAB)
Controlled Oral Word Association (COWA)
Hopkins Verbal Learning Test-Revised (HVLT-R)
Self-reported cognition
Post-intervention at week 12
Feasibility of the intervention

Trial Safety

Trial Design

1 Treatment Group

1 of 1
Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: E-Co · No Placebo Group · N/A

Experimental Group · 1 Intervention: E-Co · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention at week 12

Trial Background

Prof. Kah Poh Loh, Assistant Professor
Principal Investigator
University of Rochester
Closest Location: University of Rochester · Rochester, NY
Photo of University of Rochester  1Photo of University of Rochester  2Photo of University of Rochester  3
2013First Recorded Clinical Trial
10 TrialsResearching Malignancies
554 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are ≥60 years at the time of consent.
You have completed curative intent treatments.
You have a score of ≤10 on the FACT-Cog Impact of Quality of Life Scale21.
You have an ECOG performance status of 0-3.
You are able to walk 4 meters.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.